JULY 31 - Health Velocity Capital today announced that Saurabh Bhansali has joined the firm as a Partner and will be based in the firm’s San Francisco office.

Saurabh joins the firm from Humana (NYSE: HUM), one the nation’s leading healthcare companies and the second largest Medicare Advantage insurer in the country, where he helped build and lead Humana Health Ventures.  At Humana, Saurabh led an investment in Aspire Health, an important and leading provider of palliative and end-of-life care management, and was also actively involved with investments in Omada Health and Livongo Health, both first-movers in digital health management in pre-diabetes and Type II Diabetes respectively.  In addition to his formal investing responsibilities, he was also a key member in driving discovery and innovation efforts across Humana’s enterprise, developed best practices to drive the right innovative companies and themes throughout the company, and was recognized as a Rising Star by the Global Corporate Venturing organization in 2017.  Prior to Humana, Saurabh was on the investing team at HLM Venture Partners, where he was involved in investments in Binary Fountain and AbleTo and served as a Board Observer at Vericare Management (acquired by MedOptions) and Imagine Health. He also held roles at Ferrer Freeman & Co. as part of the investing team, at Bank of America Merrill Lynch as an investment banker, and at Pfizer as part of the mergers, acquisitions and licensing team.  

According to Bhansali, “I couldn’t be more excited to be a part of the Health Velocity Capital team or about our singular focus of supporting healthcare software and services innovators in pursuit of a high quality, affordable, consumer-friendly, and sustainable healthcare system.”

Marty Felsenthal added, “We feel very fortunate to have Saurabh join our organization.  He was a trusted colleague of mine for a number of years at HLM Venture Partners, and he has enjoyed a strong and longstanding friendship with both Bruce and me.”

Partner Bruce Crosby noted, “Driving innovations that lower healthcare costs, facilitate the transition to value-based care, use software to push efficiencies through the healthcare system, and root out waste and poor quality has never been more important.  We believe Saurabh’s on-the-ground experience at Humana and prior investing experience will be invaluable as we work to identify and support entrepreneurs focused on improving our nation’s healthcare system.”

About Health Velocity Capital
Health Velocity Capital has offices in San Francisco, CA, and Nashville, TN, and invests exclusively in post-commercial stage, innovative healthcare software and services companies.  The firm’s partners have more than 50 collective years of experience investing in, and building and managing as entrepreneurs and senior executives, companies that created important new healthcare markets and/or that became market leaders.  Some of these companies (which include Health Velocity Capital investments as well as investments and prior operating companies from predecessor roles) have included Teladoc, Change Healthcare, Aperio, Payerpath, Vantage Oncology, Vericare, ClearDATA Networks, Titan Health, US Renal Care, Compassus, Healthways, D2Hawkeye, iTriage, National Surgical Care, Iasis, The Advisory Board Company, Aspire Health, Omada Health, and Livongo Health.  Health Velocity Capital invests on behalf of financial institutions, a collection of senior healthcare executives investing individually, and a number of strategic investors who collectively provide insurance coverage to more than 50 million Americans and who operate more than and employ more than 8,000 physicians.  For more information, visit